BPA Call 36C26218A0023-36C26222N0572
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic solutions, was awarded a contract valued at $66,029.21 by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) for inhalation therapy services supporting Veterans Administration medical facilities in California. The contract, awarded June 1, 2021, was issued as a call against an existing Blanket Purchase Agreement (BPA) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB)...
- This federal contract award to INO Therapeutics LLC is for the provision of INO-therapy services to the VA Greater Los Angeles and San Diego Healthcare Systems (VAGLHS and VASDHS), part of Veterans Integrated Service Network (VISN) 22. The Blanket Purchase Agreement (BPA) call, valued at $91,592.95, was awarded under the Pharmaceuticals and Drugs GSA Schedule without any set-aside designation. As the prime contractor, INO Therapeutics will deliver inhaled nitric oxide gas, equipment, and related...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide therapeutic gases and respiratory therapy systems, was awarded a delivery order valued at $51,982.38 by Veterans Integrated Service Network 22, a civilian component of the Department of Veterans Affairs. The contract, issued March 1, 2024, with an ultimate completion date of February 28, 2025, operates under a firm fixed-price structure and is classified as a non-set-aside award. Performance will be executed at the...
- INO Therapeutics LLC, a Hazelwood, Missouri-based supplier of inhaled nitric oxide (INO) therapeutic gases and related medical services, was awarded a $321,643 firm fixed-price delivery order by Veterans Integrated Service Network 10 on April 27, 2022. This non-set-aside contract, with an ultimate completion date of April 26, 2027, falls under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) and represents a task order issued against a larger Indefinite Delivery/Indefinite...
- INO Therapeutics LLC, a Missouri-based supplier of specialized respiratory therapeutics, has been awarded a delivery order valued at $28,784 by the Department of Veterans Affairs Veterans Integrated Service Network 21 for the supply of INOMAX (nitric oxide) therapeutic gas and related inhalation therapy services. This delivery order, issued under a firm fixed-price arrangement with no set-aside designation, represents a child contract under the Pharmaceuticals and Drugs GSA Supply Schedule...
- On December 1, 2022, the Department of Veterans Affairs' Veterans Integrated Service Network 22 awarded a delivery order to INO Therapeutics LLC for inhaled nitric oxide therapy and nitric oxide services at a ceiling value of $11,360.52. This firm fixed-price contract, with an ultimate completion date of February 28, 2023, will be performed in San Diego, California. The award represents a task order issued under INO Therapeutics' existing Blanket Purchase Agreement with VISN 2, established...
- INO Therapeutics LLC, a Missouri-based supplier of inhaled nitric oxide (INO) therapeutic solutions, received a delivery order valued at $53,381.63 from Veterans Integrated Service Network 19 (VISN 19) for the provision of inotherapy nitric oxide gas therapy and related services. Issued as a firm fixed-price contract on May 27, 2021, with an ultimate completion date of May 26, 2026, this non-set-aside delivery order will be performed in Hazelwood, Missouri. The contract represents a continuation...
- The Department of Veterans Affairs' Veterans Integrated Service Network 19 awarded a $53,970 firm fixed-price purchase order to INO Therapeutics LLC on May 27, 2026, for the supply of inhaled nitric oxide (INO) therapy services. This contract, which extends through December 31, 2030, was awarded as a sole-source procurement under FAR 8.405-6(a)(2) to support the Rocky Mountain Regional VA Medical Center's critical care operations. INO Therapeutics, a large business headquartered in Hazelwood,...
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a $10,794.00 delivery order to INO Therapeutics LLC on March 1, 2026, for the provision of nitric oxide gas services with an ultimate completion date of August 31, 2026. This is a firm fixed-price contract with no set-aside designation, issued as a child order under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB). The work will be performed in San Diego, California, supporting the VA's healthcare...
- This is a delivery order awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to INO Therapeutics LLC, a foreign-owned for-profit company. The $2,194.83 firm-fixed-price contract is for the delivery of inhaled nitric oxide (INO) therapy systems and related medical gases to support respiratory treatments for veterans and military beneficiaries. INO Therapeutics is an experienced federal contractor, having been awarded over 50 VA and...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D60737-36C26218A0023Blanket Purchase Agreement
- 36C26218A0023-36C26222N0572BPA Call
INO Therapeutics LLC was awarded a Blanket Purchase Agreement (BPA) call valued at $59,897.91 by Veterans Integrated Service Network 22 (VISN 22), a component of the Department of Veterans Affairs, for the provision of inhalation therapy services at VA Greater Los Angeles Healthcare System and VA San Diego Healthcare System. Issued on June 1, 2022, with completion targeted for November 30, 2022, this firm fixed-price contract was executed under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) with no set-aside designation. INO Therapeutics LLC, a Missouri-based supplier specializing in inhaled nitric oxide therapeutic gas and related medical services, has established itself as a critical vendor to the VA and Defense Health Agency for specialized respiratory therapy delivery systems. The contract represents a task order against INO Therapeutics LLC's existing BPA vehicle, leveraging the company's established relationship with VISN 22 to supply inhaled nitric oxide therapy services to veterans and military beneficiaries across two major Southern California VA medical facilities. The company's experience delivering inhalation therapy solutions across multiple VISN networks and military medical centers, combined with its ongoing IDV contracts valued in the millions of dollars, positions it to meet the clinical and logistical demands of providing specialized respiratory treatments in federal healthcare settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($24k) | 10/30/25 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 8/23/22 | |
| Not listed | Not listed | $84.3k | 5/31/22 |